CytoSorb® Receives Marketing Approval in Mexico with Commercialization to Commence with Partner Fresenius Medical Care
- Tuesday, March 31, 2020, 7:02
- Finance
- Add a comment
MONMOUTH JUNCTION, N.J., March 31, 2020 /PRNewswire/ — CytoSorbents Corporation (NASDAQ: CTSO) a critical care immunotherapy leader commercializing its CytoSorb® blood purification technology to treat cytokine storm and deadly inflammation in critically-ill and cardiac surgery patients…
About the Author
adminasapcorp has written 38957 stories on this site.